- risk factors for disease progression
- epidemiological studies
Early Lyme disease (epidemiology)
- predictors of outcome
- post-Lyme syndrome
Weinstein A, Bujak DI, Mittelman A, Davidian M. Erythema nodosum in a patient with renal cell carcinoma treated with interleukin 2 and lymphokine-activated killer cells. JAMA 1987; 258,21:3120-3121.
Weinstein A, Bujak DI. Lyme disease: a review of its clinical features. New York State Journal of Medicine 1989, 89:566-571.
Asch ES, Bujak DI, Weiss M, Peterson MGM, Weinstein A. Lyme disease: An infectious and post-infectious syndrome. J Rheumatol 1994, 21:454-461.
Asch ES, Bujak DI, Weinstein A. Long-term clinical outcomes of Lyme disease. Annals of Internal Medicine 1995, 122:960.
Bujak DI, Weinstein A, Dornbush RL. Clinical and neurocognitive features of post Lyme syndrome. J Rheumatol 1996, 23:1392-1397.
Bujak DI, Guardino S, Weinstein A. Lyme disease. Lippincott’s Primary Care Practice. 1998, 2(1):87-92.
Bujak DI. Daily hassles, trait-anxiety, and cognitive appraisal of stress in early Lyme disease as predictors of health status at follow-up. Dissertation Abstracts International. 1998, UMI 9819851.
Fallon J, Bujak DI, Guardino S, Weinstein A. The Fibromyalgia Impact Questionnaire: A useful tool in evaluating patients with post-Lyme disease syndrome. Arthritis Care Research 1999, 12(1):42-47